Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05379283 · ClinicalTrials.gov registry record · NA
Does Topical Lidocaine Decrease Sweat During Exercise in the Heat?
A NA study of Sweat Pore Closure, sponsored by San Diego State University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05379283: Completed NA study of Sweat Pore Closure, sponsored by San Diego State University.
NCT05379283 is a NA study of Sweat Pore Closure that has completed, run by San Diego State University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05379283, a NA study of Sweat Pore Closure, has completed, sponsored by San Diego State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Subjects will walk on a treadmill at 3 mph and sweat will be collected from both forearms. One arm will be pretreated with topical lidocaine, and the other will act as the control.
Primary Outcome
Volume of sweat produced during exercise following tipocal lidocaine
Conditions Studied
Interventions
- DRUG Lidocaine
- OTHER control
Study Locations (1)
California
- San Diego State University - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-05-15 |
| Est. Completion | 2022-09-15 |
| Phase | NA |
What the finished NCT05379283 record still lists
NCT05379283 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Sweat Pore Closure appearing as the primary indexed condition, and to 2 interventions - of which Lidocaine is the first listed.
NCT05379283 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05379283 about?
NCT05379283 is a clinical study titled "Does Topical Lidocaine Decrease Sweat During Exercise in the Heat?". Subjects will walk on a treadmill at 3 mph and sweat will be collected from both forearms. One arm will be pretreated with topical lidocaine, and the other will act as the control.
What is the current status of trial NCT05379283?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-05-15. Estimated completion is 2022-09-15.
What conditions does trial NCT05379283 study?
This clinical trial studies the following conditions: Sweat Pore Closure.
What interventions are being tested in trial NCT05379283?
The interventions under investigation include: Lidocaine (DRUG), control (OTHER).
Who is sponsoring clinical trial NCT05379283?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05379283 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05379283's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI